{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:27:29Z","timestamp":1782988049024,"version":"3.54.5"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,9,14]]},"DOI":"10.18632\/aging.204271","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T17:04:16Z","timestamp":1662397456000},"page":"7052-7064","source":"Crossref","is-referenced-by-count":5,"title":["Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis\/bladder pain syndrome"],"prefix":"10.18632","volume":"14","author":[{"given":"Guang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710061, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Xin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong-Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ye","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710061, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Lin","family":"He","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710061, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.14670\/HH-18-028","article-title":"Pathology and terminology of interstitial cystitis\/bladder pain syndrome: A review.","volume":"3","author":"Maeda","year":"2019","journal-title":"Histol Histopathol"},{"key":"2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment.","volume":"19","author":"Faraday","year":"2015","journal-title":"J Urol"},{"key":"3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/21681805.2020.1730948","article-title":"Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report.","volume":"5","author":"Quaghebeur","year":"2020","journal-title":"Scand J Urol"},{"key":"4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnins.2012.00114","article-title":"Co-morbidities of interstitial cystitis.","volume":"6","author":"Chelimsky","year":"2012","journal-title":"Front Neurosci"},{"key":"5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal.","volume":"5","author":"Osborne","year":"2008","journal-title":"Eur Urol"},{"key":"6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.juro.2006.09.054","article-title":"Highlights from the combined Society of Urodynamics and Female Urology, and International Society of Pelvic Neuromodulation annual meeting.","volume":"17","author":"Te","year":"2007","journal-title":"J Urol"},{"key":"7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/nau.23900","article-title":"GAG replenishment therapy for bladder pain syndrome\/interstitial cystitis.","volume":"3","author":"Cervigni","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/iju.13985","article-title":"Pathophysiology of interstitial cystitis.","volume":"2","author":"Birder","year":"2019","journal-title":"Int J Urol"},{"key":"9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.cyto.2018.05.012","article-title":"IL-33 mast cell axis is central in LL-37 induced bladder inflammation and pain in a murine interstitial cystitis model.","volume":"11","author":"Oottamasathien","year":"2018","journal-title":"Cytokine"},{"key":"10","first-page":"411","article-title":"Proliferation and transepithelial migration of mucosal mast cells in interstitial cystitis.","volume":"5","author":"Enerb\u00e4ck","year":"1986","journal-title":"Immunology"},{"key":"11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18565\/urology.2020.2.31-34","article-title":"[Experimental evaluation of interaction of the nerve growth factor and mast cells in patients with interstitial cystitis\/bladder pain syndrome].","volume":"2","author":"Sholan","year":"2020","journal-title":"Urologiia"},{"key":"12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrurol.2012.217","article-title":"Intravesical treatments of bladder pain syndrome\/interstitial cystitis.","volume":"9","author":"Schwalenberg","year":"2012","journal-title":"Nat Rev Urol"},{"key":"13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1517\/13543784.2016.1162290","article-title":"Investigational drugs for bladder pain syndrome (BPS) \/ interstitial cystitis (IC).","volume":"2","author":"Tyagi","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1152\/physrev.1997.77.4.1033","article-title":"Mast cells.","volume":"7","author":"Mekori","year":"1997","journal-title":"Physiol Rev"},{"key":"15","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.3390\/ijms20184397","article-title":"Future Needs in Mast Cell Biology.","volume":"2","author":"Galli","year":"2019","journal-title":"Int J Mol Sci"},{"key":"16","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.3390\/ijms21113835","article-title":"Phenotypic and Functional Diversity of Mast Cells.","volume":"2","author":"Tanaka","year":"2020","journal-title":"Int J Mol Sci"},{"key":"17","doi-asserted-by":"publisher","first-page":"110157","DOI":"10.1016\/j.biopha.2020.110157","article-title":"Novel reactivation and degranulation of mast cells.","volume":"12","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jclinpath-2017-204881","article-title":"Distribution of mast cell subtypes in interstitial cystitis: implications for novel diagnostic and therapeutic strategies?","volume":"7","author":"Lwaleed","year":"2018","journal-title":"J Clin Pathol"},{"key":"19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urology.2006.08.1109","article-title":"The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis.","volume":"6","author":"Theoharides","year":"2007","journal-title":"Urology"},{"key":"20","first-page":"3717","article-title":"Stem cell factor is a chemotactic factor for human mast cells.","volume":"15","author":"Siegbahn","year":"1994","journal-title":"J Immunol"},{"key":"21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF01605152","article-title":"Nerve fibre proliferation in interstitial cystitis.","volume":"41","author":"Turner-Warwick","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12974-019-1671-5","article-title":"Palmitoylethanolamide counteracts substance P-induced mast cell activationby stimulating diacylglycerol lipase activity.","volume":"1","author":"Di Marzo","year":"2019","journal-title":"J Neuroinflammation"},{"key":"23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1600-065X.2008.00741.x","article-title":"Bruton\u2019s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain.","volume":"22","author":"Smith","year":"2009","journal-title":"Immunol Rev"},{"key":"24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/bies.950181009","article-title":"X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.","volume":"1","author":"Smith","year":"1996","journal-title":"Bioessays"},{"key":"25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton\u2019s tyrosine kinase in B cells and malignancies.","volume":"1","author":"Hendriks","year":"2018","journal-title":"Mol Cancer"},{"key":"26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-016-0282-1","article-title":"Novel agents in the treatment of multiple myeloma: a review about the future.","volume":"9","author":"Abdul-Hay","year":"2016","journal-title":"J Hematol Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/13543784.2016.1182499","article-title":"Investigational Bruton\u2019s tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.","volume":"2","author":"Norman","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"28","doi-asserted-by":"publisher","first-page":"15467","DOI":"10.1038\/s41598-018-33769-1","article-title":"Stimulus strength determines the BTK-dependence of the SHIP1-deficient phenotype in IgE\/antigen-triggered mast cells.","volume":"8","author":"Huber","year":"2018","journal-title":"Sci Rep"},{"key":"29","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1172\/JCI138448","article-title":"Bruton\u2019s tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis.","volume":"13","author":"Bochner","year":"2020","journal-title":"J Clin Invest"},{"key":"30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/vco.12520","article-title":"Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.","volume":"1","author":"Hadzijusufovic","year":"2019","journal-title":"Vet Comp Oncol"},{"key":"31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jaci.2015.08.056","article-title":"Nonreceptor tyrosine kinases ITK and BTK negatively regulate mast cell proinflammatory responses to lipopolysaccharide.","volume":"13","author":"August","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"32","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1242\/jcs.071043","article-title":"Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells.","volume":"12","author":"Gilfillan","year":"2010","journal-title":"J Cell Sci"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:24:10Z","timestamp":1663719850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":32,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022,9,14]]}},"alternative-id":["204271","36069808"],"URL":"https:\/\/doi.org\/10.18632\/aging.204271","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}